FCGR3A and breast cancer: reported an Fc-optimized NKG2D-Fc construct, carrying the SDIE modification, which enhanced degranulation, ADCC, and IFN-γ production of NK cells in response to BC cells, independently of FcγRIIIa-V158F polymorphism (154).